etravirine
- Product NDC
- 69452-254
- 11-digit product format
- 694520254
- Labeler code
- 69452
- Product ID
- 69452-254_458bb39e-2e86-b4b4-e063-6394a90ae867
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- etravirine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bionpharma Inc.
- Application
- ANDA219152
- Marketing category
- ANDA
- Marketing start
- 2026-01-01
- Substance
- ETRAVIRINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- etravirine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETRAVIRINE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0C50HW4FO1 |
| Rxcui | 754761, 1052658 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69452-254-22 | etravirine | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69452-254-22 | 69452025422 | 120 TABLET in 1 BOTTLE, PLASTIC (69452-254-22) | 120 tablet | 2026-01-01 | No | No | Historical |